NeuroPace, Inc. (NPCE)
7.95
-0.19
(-2.33%)
USD |
NASDAQ |
Nov 20, 16:00
8.06
+0.11
(+1.38%)
After-Hours: 20:00
NeuroPace Debt to Equity Ratio : 6.051 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.051 |
| June 30, 2026 | 5.885 |
| March 31, 2026 | 4.875 |
| December 31, 2025 | 3.722 |
| September 30, 2025 | 3.844 |
| June 30, 2025 | 3.679 |
| March 31, 2025 | 3.014 |
| December 31, 2024 | 9.152 |
| September 30, 2024 | 7.482 |
| June 30, 2024 | 7.452 |
| March 31, 2024 | 5.096 |
| December 31, 2023 | 3.505 |
| Date | Value |
|---|---|
| September 30, 2023 | 4.382 |
| June 30, 2023 | 3.346 |
| March 31, 2023 | 2.560 |
| December 31, 2022 | 2.006 |
| September 30, 2022 | 1.574 |
| June 30, 2022 | 1.081 |
| March 31, 2022 | 0.9068 |
| December 31, 2021 | 0.6782 |
| September 30, 2021 | 0.6068 |
| June 30, 2021 | 0.5566 |
| March 31, 2021 | -3.773 |
| December 31, 2020 | -8.305 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tandem Diabetes Care, Inc. | 5.452 |
| Axogen, Inc. | 0.0392 |
| Accuray, Inc. | 2.560 |
| Orthofix Medical, Inc. | 0.6101 |
| ResMed, Inc. | 0.1027 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 94.78M |
| Total Liabilities (Quarterly) | 83.28M |
| Shareholders Equity (Quarterly) | 11.49M |
| Current Ratio | 5.261 |
| Net Debt Paydown Yield | 0.08% |